Compare ELF & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELF | TMDX |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.2B |
| IPO Year | 2016 | 2019 |
| Metric | ELF | TMDX |
|---|---|---|
| Price | $85.81 | $137.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 8 |
| Target Price | $127.00 | ★ $144.25 |
| AVG Volume (30 Days) | ★ 1.6M | 659.2K |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 170.70 |
| EPS | 1.40 | ★ 2.54 |
| Revenue | ★ $1,385,640,000.00 | $566,354,000.00 |
| Revenue This Year | $20.59 | $38.81 |
| Revenue Next Year | $16.79 | $20.49 |
| P/E Ratio | $58.71 | ★ $54.13 |
| Revenue Growth | 13.80 | ★ 41.20 |
| 52 Week Low | $49.40 | $55.00 |
| 52 Week High | $150.99 | $156.00 |
| Indicator | ELF | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 61.87 |
| Support Level | $75.73 | $120.17 |
| Resistance Level | $80.87 | $133.29 |
| Average True Range (ATR) | 3.45 | 4.87 |
| MACD | 1.22 | 1.34 |
| Stochastic Oscillator | 82.61 | 90.00 |
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.